QUANTERIX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.56 USD | -0.19% |
|
-1.71% | -43.09% |
| Apr. 12 | Quanterix Corporation Announces Laurie Olson, Director Will Not Stand for Re-Election | CI |
| Mar. 25 | Transcript : Quanterix Corporation - Special Call |
Presenter SpeechUnknown Analyst (Analysts)Hi, everyone. My name is [indiscernible] . I'm on th...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.
Calendar
2024-05-06
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.56
USD
Average target price
29.8
USD
Spread / Average Target
+91.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -43.09% | 595M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- QTRX Stock
- News Quanterix Corporation
- Transcript : Quanterix Corporation Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 03
